Novel candidates synthesis of indenopyrazole, indenoazine and indenothiophene, with anticancer and in silico studies

Magda H. Abdellattif*, Mohammed Gomma Assy, Ahmed Elfarargy, Fawzy Ramadan, Marwa S. Elgendy, Abdul Hamid M. Emwas, Mariusz Jaremko, Wesam S. Shehab

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: The indandione nucleus, is one of the most amazing nuclei in medicinal chemistry, is used to design new derivatives. Methods & materials: Novel indandione derivatives are prepared with different electrophilic and nucleophilic reagents to yield 3, 4, 8, 11, 14, 16, 19, 20, 21, 22 and 23. Compounds 8, 11, 16, 20 and 23 are investigated against OVCAR-3 and HeLa, using LLC-MK2 and cis-Pt as references. in silico and spectral studies were analyzed for the selected compounds. Results: Compounds 20 and 23 at 100 ns were the most potent compounds, so molecular dynamics studies were performed. Conclusion: Compound 23 was the most active toward the HeLa cervical cell line, and compound 20 was the most active toward the Ovcar-3 cell line.

Original languageEnglish (US)
Pages (from-to)1429-1447
Number of pages19
JournalFuture Medicinal Chemistry
Volume16
Issue number14
DOIs
StatePublished - 2024

Keywords

  • anticancer
  • in silico studies
  • indenopyrane
  • indenopyrazole
  • mercaptopyrazole

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Novel candidates synthesis of indenopyrazole, indenoazine and indenothiophene, with anticancer and in silico studies'. Together they form a unique fingerprint.

Cite this